Paper Details

  1. Home
  2. Paper Details

M1 receptors play a central role in modulating AD-like pathology in transgenic mice.

Author: BillingsLauren M, CaccamoAntonella, FisherAbraham, GreenKim N, LaFerlaFrank M, Martinez-CoriaHilda, OddoSalvatore

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

AF267B, a selective M1 muscarinic agonist, was found to improve cognitive function in a mouse model of Alzheimer's disease. AF267B reduced amyloid beta and tau pathology in the hippocampus and cortex, and reversed cognitive deficits in a spatial task.
Paper Details　
Original Abstract of the Article :
We investigated the therapeutic efficacy of the selective M1 muscarinic agonist AF267B in the 3xTg-AD model of Alzheimer disease. AF267B administration rescued the cognitive deficits in a spatial task but not contextual fear conditioning. The effect of AF267B on cognition predicted the neuropatholog...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.neuron.2006.01.020

データ提供：米国国立医学図書館（NLM）

M1 Receptors: A Key Player in Modulating Alzheimer's Disease Pathology

The desert of Alzheimer's disease (AD) is a vast and challenging terrain, filled with cognitive decline, memory loss, and other debilitating symptoms. This study, like a team of intrepid desert researchers, investigated the therapeutic potential of targeting M1 muscarinic receptors, a type of receptor involved in brain function, as a potential treatment for AD. They used a transgenic mouse model of AD to evaluate the effects of the selective M1 muscarinic agonist AF267B. They found that AF267B, like a carefully placed oasis, rescued cognitive deficits in a spatial task and reduced both amyloid-beta (Abeta) and tau pathology in the hippocampus and cortex. This research provides promising evidence for the potential of M1 agonists in treating AD.

Targeting M1 Receptors: A New Approach to Alzheimer's Disease Treatment

This research offers a glimmer of hope in the vast desert of Alzheimer's disease, highlighting the potential of targeting M1 receptors as a therapeutic approach. The study's findings suggest that selective M1 agonists, like carefully chosen tools in the desert, could potentially improve cognitive function and reduce the progression of AD pathology.

The Impact on Health and Everyday Life

The study's findings could revolutionize the treatment of Alzheimer's disease, offering a potential path to improved cognitive function and a better quality of life for those living with this devastating condition. The research emphasizes the importance of ongoing research to further explore the therapeutic potential of M1 agonists and develop effective treatments for AD.

Dr. Camel's Conclusion

This study presents a promising oasis in the desert of Alzheimer's disease, showcasing the potential of targeting M1 receptors as a therapeutic strategy. The findings provide a valuable starting point for further research and development of effective treatments for this devastating condition, offering hope for a brighter future for those affected by AD.

Date :
  1. Date Completed 2006-05-09
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

16504943

DOI: Digital Object Identifier

10.1016/j.neuron.2006.01.020

Related Literature

Article Analysis
・Effects of dicyclomine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.